Dermatology Life Quality Index in Thai Patients with Facial Port-Wine Stains
Tóm tắt
Port-wine stains (PWS) are congenital capillary abnormalities caused by immature, venule-like vasculature that progressively dilates due to poor endothelial cell differentiation. PWS affects between 0.3% and 0.9% of newborns, with 90% of cases occurring on the face. Individuals with facial PWS and their parents had a significant negative impairment on their quality of life (QoL) and also suffered from psychological disabilities. This was a cross-sectional questionnaire-based survey study in Thailand from July 2021 to April 2022. The questionnaires included demographic data, subjective evaluation (SE), and the Dermatology Life Quality Index (DLQI). The questionnaire was performed with a full scale and adjusted scale of validity and reliability test of DLQI using factor analysis and Cronbach’s alpha. The study outcome was a subjective evaluation and DLQI in patients who received pulsed dye laser (PDL) treatment. Of the 54 patients, 35.2% (19) are male, and 64.8% (35) are female. Regarding age groups, 64.8% (35) are below 5 years old, and 35.2% (19) are older than 5 years. SE results showed that males evaluated an improvement of the facial PWS lesion significantly better than females (P < 0.05). The older age group graded the percentage of improvement better than the younger age group (P < 0.01). The result of the DLQI showed no difference in DLQI between gender. Older age result resulted in a significantly different DLQI compared with younger age (P < 0.01). Parent-reported DLQI improvement was less than self-reported DLQI improvement in patients with PWS treated with PDL (P < 0.05). Concerning the instrument of the study, the validity and reliability analysis of the DLQI questionnaire using factor analysis and Cronbach’s alpha have been performed. The adjusted scale with the 5-item DLQI questionnaire is more appropriate in terms validity and reliability. This study demonstrates that facial PWS reduces the QoL as measured by DLQI. We discovered that the QoL of patients and parents with PWS was significantly impaired. The main influencing factors were older age, the improved perception between gender, and PDL treatments. In addition, we found only five questions that are reliable for PWS. The adjusted five-item DLQI questionnaires are more appropriate regarding validity and reliability. TCTR20230210001, COA no. si 1059/2020.
Tài liệu tham khảo
Tan W, Wang J, Zhou F, Gao L, Yin R, Liu H, et al. Coexistence of Eph receptor B1 and ephrin B2 in port-wine stain endothelial progenitor cells contributes to clinicopathological vasculature dilatation. Br J Dermatol. 2017;177(6):1601–11.
Nguyen V, Hochman M, Mihm MC Jr, Nelson JS, Tan W. The pathogenesis of port wine stain and Sturge Weber syndrome: complex interactions between genetic alterations and aberrant MAPK and PI3K activation. Int J Mol Sci. 2019;20(9):2243.
van Raath MI, Bambach CA, Dijksman LM, Wolkerstorfer A, Heger M. Prospective analysis of the port-wine stain patient population in the Netherlands in light of novel treatment modalities. J Cosmet Laser Ther. 2018;20(2):77–84.
Klein A, Bäumler W, Landthaler M, Babilas P. Laser and IPL treatment of port-wine stains: therapy options, limitations, and practical aspects. Lasers Med Sci. 2011;26(6):845–59.
van Drooge AM, Beek JF, van der Veen JW, van der Horst CM, Wolkerstorfer A. Hypertrophy in port-wine stains: prevalence and patient characteristics in a large patient cohort. J Am Acad Dermatol. 2012;67(6):1214–9.
Heiser A, Jowett N, Occhiogrosso J, Tessler O, Tan OT. Societal-perceived health utility of hypertrophic facial port-wine stain and laser treatment. Facial Plast Surg Aesthetic Med. 2020;22(5):327–35.
De Borgie C, Bossuyt P, van der Horst C, van Gemert M. Introduction of the flash-lamp pulsed-dye laser treatment of facial port-wine stains in childhood: a case of health care technology assessment. Lasers Surg Med. 2001;28(2):182–9.
Sarig O, Kimel S, Orenstein A. Laser treatment of venous malformations. Ann Plast Surg. 2006;57(1):20–4.
Garden JM, Polla LL, Tan OT. The treatment of port-wine stains by the pulsed dye laser: analysis of pulse duration and long-term therapy. Arch Dermatol. 1988;124(6):889–96.
Sommer S, Sheehan-Dare RA. Pulsed dye laser treatment of port-wine stains in pigmented skin. J Am Acad Dermatol. 2000;42(4):667–71.
Wanitphakdeedecha R, Jantarakolica T, Ng JNC, Yan C, Nanchaipruek Y, Jantanapornchai N, et al. The cost-effectiveness of pulsed-dye laser therapy among Thai patients with facial port-wine stain: a retrospective study and economic evaluation. Dermatol Ther (Heidelb). 2021;11(2):465–73.
Wanitphakdeedecha R, Ng JNC, Yan C, Manuskiatti W, Sudhipongpracha T, Jantarakolica T. Quality of life and psychological effects of port-wine stain: a review of literature. Clin Cosmet Investig Dermatol. 2021;14:681.
van Raath MI, Chohan S, Wolkerstorfer A, van der Horst CM, Limpens J, Huang X, et al. Treatment outcome measurement instruments for port wine stains: a systematic review of their measurement properties. Dermatology. 2021;237(3):416–32.
Finlay AY, Khan G. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.
Hagen SL, Grey KR, Korta DZ, Kelly KM. Quality of life in adults with facial port-wine stains. J Am Acad Dermatol. 2017;76(4):695–702.
Masnari O, Schiestl C, Rössler J, Gütlein SK, Neuhaus K, Weibel L, et al. Stigmatization predicts psychological adjustment and quality of life in children and adolescents with a facial difference. J Pediatr Psychol. 2013;38(2):162–72.
van der Horst CM, De Borgie CA, Knopper JL, Bossuyt PM. Psychosocial adjustment of children and adults with port wine stains. Br J Plast Surg. 1997;50(6):463–7.
Lanigan S, Cotterill J. Psychological disabilities amongst patients with port wine stains. Br J Dermatol. 1989;121(2):209–15.
Wanitphakdeedecha R, Sudhipongpracha T, Ng JNC, Yan C, Jantarakolica T. Self-stigma and psychosocial burden of patients with port-wine stain: a systematic review and meta-analysis. J Cosmet Dermatol. 2021;20(7):2203–10.
Rencz F, Szabó Á, Brodszky V. Questionnaire modifications and alternative scoring methods of the dermatology life quality index: a systematic review. Value Health. 2021;24(8):1158–71.
Demellweek C, Humphris GM, Hare M, Brown J. Children’s perception of, and attitude towards, unfamiliar peers with facial port-wine stains. J Pediatr Psychol. 1997;22(4):471–85.
Jantarakolica T, Wanitphakdeedecha R, Yan C, Yogya Y, Sirisuthivoranunt S, Wongdama S, et al. Willingness to pay and time trade-off in Thai patients with port-wine stains. ClinicoEcon Outcomes Res. 2022;14:635–42.
Craig BM, Greiner W, Brown DS, Reeve BB. Valuation of child health-related quality of life in the United States. Health Econ. 2016;25(6):768–77.
Ravens-Sieberer U, Karow A, Barthel D, Klasen F. How to assess quality of life in child and adolescent psychiatry. Dialogues Clin Neurosci. 2022.
Wang J, Zhu Y-Y, Wang Z-Y, Yao X-H, Zhang L-F, Lv H, et al. Analysis of quality of life and influencing factors in 197 Chinese patients with port-wine stains. Medicine. 2017;96(51): e9446.
Gånemo A, Wahlgren CF, Svensson Å. Quality of life and clinical features in Swedish children with psoriasis. Pediatr Dermatol. 2011;28(4):375–9.
Hamann C, Egeberg A, Silverberg J, Gislason G, Skov L, Thyssen J. Exploring the association between parental psychiatric disease and childhood atopic dermatitis: a matched case–control study. J Eur Acad Dermatol Venereol. 2019;33(4):725–34.
Cazeau C, Blei F, Gonzáles Hermosa MRF, Cavalli R, Boccara O, Fölster-Holst R, et al. Burden of infantile hemangioma on family: an international observational cross-sectional study. Pediatr Dermatol. 2017;34(3):295–302.
Andrade G, Rangu S, Provini L, Putterman E, Gauthier A, Castelo-Soccio L. Childhood vitiligo impacts emotional health of parents: a prospective, cross-sectional study of quality of life for primary caregivers. J Patient-Report Outcomes. 2020;4(1):1–5.
Jiang F, Shao J, Chen L, Yang N, Liu J, Li Z. Influence of port-wine stains on quality of life of children and their parents. Acta Derm Venereol. 2021;101(8): adv00516.